The Crikey Register of Influence – which details links between opinion leaders, organisations and industry marketing campaigns – has been updated.
The new entries are Professor Simon Stewart, Head, Preventive Cardiology at the Baker IDI Heart and Diabetes Institute, and his colleague, Dr Melinda Carrington, General Manager of the Baker’s Disease Management and Preventative Programs.
They appeared [...]
In a Crikey piece published today, Dr Rosemary Stanton has subjected the composition of the Food Standards Australia NZ board to some critical analysis. Her conclusion is that the interests of public health are under-represented, especially in comparison with the strong representation of industry.
Does this matter? Why should public health interests be better represented?
Croakey has [...]
When the NHMRC convened a workshop on conflicts of interest in Canberra recently, participants were told that Australia had been slower than some other countries to take steps to minimise the impact of such conflicts upon research and clinical practice.
In the piece below, Sydney dermatologist Dr Chris Commens argues that unless the medical profession smartens [...]
In case there are any researchers or journalists out there with too much time on their hands, here are two ideas for stories or research projects.
• What is the role of the media in Mr Ward’s death?
The 4 Corners report on the death of Mr Ward, an Aboriginal man who was incarcerated in the most [...]
By Croakey
|
Also posted in Crikey register of influence, Health inequalities, Indigenous health, Media-related issues, adverse events
|
Tagged 4 Corners, Baker IDI Heart and Diabetes Institute, media, Mr Ward, NHMRC, prisoners, Sanofi-Aventis
|
Members of the International Committee of Medical Journal Editors are meeting in London this month.
High on the agenda will be efforts to improve the management of conflicts of interest, according to the editor of the Medical Journal of Australia, Dr Martin Van Der Weyden. He told a workshop on such issues, convened in Canberra yesterday [...]
A Sydney doctor, who wishes to remain anonymous, has sent in the following piece examining the complexities of conflict of interest issues. It’s timely in view of the approaching NHMRC workshop on this issue, and recent debate surrounding Vioxx promotions, industry sponsored guidelines for DVT prevention, and the Baker/Sanofi deal, amongst other things.
The doctor writes:
It’s [...]
The Vioxx case in the Federal Court in Melbourne continues to produce a stream of interesting and illuminating revelations although I had to chuckle at one specialist’s efforts to downplay his profession’s skills in marketing. “I would have thought getting medical practitioners to be marketers would have been the death knell of a product because [...]
A pharmacy researcher who wishes to remain anonymous has sent in this comment regarding the funding deal between the Baker and Sanofi Aventis (for more background info, see here, and here and here):
“Agreements between not for profit research institutes and the pharmaceutical industry can be fraught with conflict, even if an iron clad contract is [...]
Professor Warwick Anderson, ceo of the NHMRC, has sent in the following comment re the guidelines controversy. (Readers with an interest in these issues may want to check out the details of a workshop being held by the NHMRC in Canberra on June 2):
“Last week, the National Health and Medical Research Council (NHMRC) released for [...]
Professor Guy Maddern, professor of surgery at the University of Adelaide, comments on the ongoing controversy over guideline development (see posts below for more background):
“The nature and content of health care needs to be constantly reviewed. This remains an enormous challenge as the impact of new developments, new understandings of disease and the access to [...]
